Pharmrica Capsule 75 mg (Pregabalin)

Adult dose

This medication is taken orally, divided into two doses per day, without regard to food. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg per day, increased to 300 mg per day within 3 to 7 days. It may be increased further up to a maximum of 600 mg at 7-day intervals if needed. - Central neuropathic pain: Starting dose of 150 mg per day, increased to 300 mg after 1 week.

Child dose

For children under 12 years of age and adolescents aged 12-17, safety and efficacy data are insufficient, and administration is not recommended.

This medication, as an antiepileptic drug, may increase the risk of suicidal thoughts or behaviors, so if symptoms of depression or mood changes appear during treatment, consult with a healthcare professional immediately. Patients with allergies to the ingredient or specific genetic conditions such as lactose intolerance should not use this medication. Diabetic patients should be cautious as weight gain after taking this medication may require adjustments to blood sugar controlling medications. If symptoms of angioedema occur, stop taking this medication immediately. Elderly patients should also exercise caution due to the increased risk of injury from dizziness or drowsiness. Vision blurring or changes in vision may occur during treatment; if symptoms persist, inform your healthcare provider. Suddenly stopping this medication may lead to withdrawal symptoms such as insomnia, headache, or anxiety, so it should be gradually reduced according to healthcare provider's instructions. Patients with a history of substance abuse may be at higher risk of abusing this medication, necessitating special caution during use. Patients with reduced kidney function need to have their medication dosage adjusted, and those with heart disease should use this medication carefully. Caution is advised when taken with other medications that have central nervous system depressant effects, as there is a risk of respiratory depression. In early pregnancy, there is a risk of fetal malformations, so pregnant women should not use this medication, and women of childbearing age should employ effective contraception. Women who are breastfeeding should consult with healthcare professionals prior to taking this medication, as it may be passed through breast milk and affect the infant. It is advisable to avoid hazardous activities such as driving or operating machinery until dizziness or drowsiness resolve. If any abnormal symptoms occur during treatment, such as skin rash, fever, or swelling, stop taking this medication immediately and inform your healthcare provider. In cases of overdose, symptoms such as drowsiness, confusion, or seizures may appear, necessitating an immediate visit to a medical institution, where blood dialysis may be required if necessary. Store this medication out of reach of children, and do not transfer to another container for safety.

Serious side effects

Hives, severe swelling (edema), angioedema, swelling of the face, around the mouth, and upper respiratory tract, chest tightness, difficulty breathing, cold sweats, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, severe skin reactions, asthma attacks, respiratory problems accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and severe headache.

Mild side effects

• Dizziness
• drowsiness
• confusion
• loss of direction
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. A cool place with a temperature between 15 and 30 degrees is suitable for storage.

Appearance

A hard capsule with a reddish-brown upper part and a white lower part, containing white powder that is white or light yellow.

Package unit

30 capsules/bottle, 60 capsules/bottle